Product image of Lacosamid Hormosan (Lacosamide) supplied by GNH India

Lacosamid Hormosan

Active Ingredient:
Lacosamide
Origin:
EU

Lacosamid Hormosan (Lacosamide)

Lacosamide, the active ingredient in Lacosamid Hormosan, is an anticonvulsant presented as an oral tablet for oral use. It is employed to treat partial‑onset seizures in patients with epilepsy, helping to stabilize neuronal activity. The medication works by modulating sodium channels, thereby reducing hyperexcitability of brain cells and improving seizure control in clinical practice. GNH India supplies Lacosamid Hormosan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with established quality assurance processes and reliable logistics.

Manufacturer / TM Owner

Hormosan Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Lacosamide is used as an adjunctive therapy for focal seizure disorders within the epilepsy disease family.
  • Partial‑onset seizures: reduces seizure frequency when added to existing antiepileptic regimens.
  • Epilepsy: contributes to overall seizure control in patients with focal epilepsy.
  • Seizure disorders: improves quality of life by decreasing seizure burden.

How It Works

  • Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neuronal membranes. By stabilizing the inactive state of these channels, it diminishes repetitive neuronal firing and reduces hyperexcitability that underlies seizure generation. This selective modulation does not significantly affect normal neuronal conduction, allowing therapeutic seizure control with a favorable safety profile. The effect is dose‑dependent and contributes to the drug’s antiepileptic efficacy observed in clinical studies.

Side Effects

Lacosamide may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Dizziness: sensation of lightheadedness or unsteadiness.
  • Nausea: mild gastrointestinal upset.
  • Headache: transient cranial discomfort.
  • Fatigue: feeling of reduced energy.
  • Visual disturbances: blurred or double vision.
  • Tremor: mild involuntary shaking.

Serious or Rare Side Effects

  • Cardiac arrhythmias: abnormal heart rhythm including PR interval prolongation.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Suicidal thoughts: emergence of depressive ideation or suicidal behavior.
  • Hypersensitivity: anaphylactic reactions or angioedema.

Precautions & Warnings

When prescribing Lacosamide, clinicians should consider several precautionary measures to ensure safe use.

  • Renal impairment: dose adjustment may be required in patients with reduced kidney function.
  • Hepatic dysfunction: monitor liver enzymes and consider dose modification.
  • Cardiac conduction: assess ECG for PR interval prolongation before initiating therapy.
  • Concomitant CNS depressants: use caution as additive central nervous system effects may occur.
  • Pregnancy and lactation: limited data; weigh potential benefits against unknown risks.
  • Store at room temperature: keep below 25°C in the original container, protect from moisture and light.

Avoid Interactions

Lacosamide can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

  • Carbamazepine: strong enzyme inducer that can markedly reduce Lacosamide plasma concentrations.
  • Phenytoin: may decrease Lacosamide levels, compromising seizure control.

Moderate Interactions (Monitor Closely)

  • CYP2C19 inhibitors (e.g., fluconazole): may increase Lacosamide exposure, requiring monitoring.
  • Anticoagulants (e.g., warfarin): potential for altered coagulation parameters.
  • Other antiepileptics (e.g., valproate): may affect tolerability and require dose adjustments.

Frequently Asked Questions

Lacosamid Hormosan contains the active ingredient Lacosamide, which is prescribed as an adjunctive treatment for partial‑onset (focal) seizures in patients with epilepsy. It helps reduce the frequency of seizures when added to a stable antiepileptic regimen.

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neuronal membranes. This action stabilizes the inactive state of the channels, limiting repetitive neuronal firing and decreasing the hyperexcitability that contributes to seizure generation.

The specific dose of Lacosamide is determined by the prescribing clinician based on the patient’s clinical condition, age, renal and hepatic function, and response to therapy. Dosage adjustments are individualized and should follow the prescriber’s instructions.

Safety data for Lacosamide in pregnancy and lactation are limited. The potential benefits must be weighed against unknown risks to the fetus or infant, and the decision should be made by the treating physician in consultation with the patient.

To request Lacosamid Hormosan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Lacosamide’s unique mechanism—enhancing slow inactivation of sodium channels—differs from many other antiepileptics that target fast inactivation or other pathways. This can offer complementary seizure control when combined with other agents, though individual response and tolerability vary.

Lacosamid Hormosan should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, light, and excessive heat to maintain stability and potency.

The medication is taken orally, typically as a tablet, and should be swallowed with water. It is usually administered once or twice daily as directed by the prescriber, with or without food depending on individual tolerance.

Serious risks include cardiac conduction abnormalities such as PR‑interval prolongation, severe skin reactions like Stevens‑Johnson syndrome, and rare psychiatric effects including suicidal thoughts. Patients should be monitored for these events, especially during treatment initiation.

Lacosamide is contraindicated in patients with known hypersensitivity to the drug or its excipients. Caution is advised in individuals with significant cardiac conduction disorders, severe renal or hepatic impairment, and in pregnant or breastfeeding women unless the benefits outweigh the risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lacosamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT